-
1
-
-
84976481860
-
-
[accessed Sep 2015]
-
Japan Diabetes Clinical Data Management Study Group (2015) [accessed Sep 2015] Available from: http://jddm. jp/index.html.
-
(2015)
-
-
-
2
-
-
0142178067
-
Ethnic differences in abdominal visceral fat accumulation between Japanese, African-Americans, and Caucasians: A metaanalysis
-
Tanaka S, Horimai C, Katsukawa F (2003) Ethnic differences in abdominal visceral fat accumulation between Japanese, African-Americans, and Caucasians: a metaanalysis. Acta Diabetol 40 Suppl 1: S302-304.
-
(2003)
Acta Diabetol
, vol.40
, pp. S302-S304
-
-
Tanaka, S.1
Horimai, C.2
Katsukawa, F.3
-
3
-
-
84904697900
-
Randomized, placebo-controlled, double-blind glycemic control trial of novel sodium-dependent glucose cotransporter 2 inhibitor ipragliflozin in Japanese patients with type 2 diabetes mellitus
-
Kashiwagi A, Kazuta K, Yoshida S, Nagase I (2014) Randomized, placebo-controlled, double-blind glycemic control trial of novel sodium-dependent glucose cotransporter 2 inhibitor ipragliflozin in Japanese patients with type 2 diabetes mellitus. J Diabetes Investig 5: 382-391.
-
(2014)
J Diabetes Investig
, vol.5
, pp. 382-391
-
-
Kashiwagi, A.1
Kazuta, K.2
Yoshida, S.3
Nagase, I.4
-
4
-
-
84882251091
-
Sodium-glucose cotransporter 2 inhibitors for type 2 diabetes: A systematic review and meta-analysis
-
Vasilakou D, Karagiannis T, Athanasiadou E, Mainou M, Liakos A, et al. (2013) Sodium-glucose cotransporter 2 inhibitors for type 2 diabetes: a systematic review and meta-analysis. Ann Intern Med 159: 262-274.
-
(2013)
Ann Intern Med
, vol.159
, pp. 262-274
-
-
Vasilakou, D.1
Karagiannis, T.2
Athanasiadou, E.3
Mainou, M.4
Liakos, A.5
-
5
-
-
33644688031
-
Glucose transporters in human renal proximal tubular cells isolated from the urine of patients with non-insulin-dependent diabetes
-
Rahmoune H, Thompson PW, Ward JM, Smith CD, Hong G, et al. (2005) Glucose transporters in human renal proximal tubular cells isolated from the urine of patients with non-insulin-dependent diabetes. Diabetes 54: 3427-3434.
-
(2005)
Diabetes
, vol.54
, pp. 3427-3434
-
-
Rahmoune, H.1
Thompson, P.W.2
Ward, J.M.3
Smith, C.D.4
Hong, G.5
-
6
-
-
84884167643
-
Efficacy and safety of canagliflozin versus glimepiride in patients with type 2 diabetes inadequately controlled with metformin (CANTATA-SU): 52 week results from a randomised, double-blind, phase 3 non-inferiority trial
-
Cefalu WT, Leiter LA, Yoon KH, Arias P, Niskanen L, et al. (2013) Efficacy and safety of canagliflozin versus glimepiride in patients with type 2 diabetes inadequately controlled with metformin (CANTATA-SU): 52 week results from a randomised, double-blind, phase 3 non-inferiority trial. Lancet 382: 941-950.
-
(2013)
Lancet
, vol.382
, pp. 941-950
-
-
Cefalu, W.T.1
Leiter, L.A.2
Yoon, K.H.3
Arias, P.4
Niskanen, L.5
-
7
-
-
84858020943
-
Effects of dapagliflozin on body weight, total fat mass, and regional adipose tissue distribution in patients with type 2 diabetes mellitus with inadequate glycemic control on metformin
-
Bolinder J, Ljunggren O, Kullberg J, Johansson L, Wilding J, et al. (2012) Effects of dapagliflozin on body weight, total fat mass, and regional adipose tissue distribution in patients with type 2 diabetes mellitus with inadequate glycemic control on metformin. J Clin Endocrinol Metab 97: 1020-1031.
-
(2012)
J Clin Endocrinol Metab
, vol.97
, pp. 1020-1031
-
-
Bolinder, J.1
Ljunggren, O.2
Kullberg, J.3
Johansson, L.4
Wilding, J.5
-
8
-
-
84892479365
-
Dapagliflozin maintains glycaemic control while reducing weight and body fat mass over 2 years in patients with type 2 diabetes mellitus inadequately controlled on metformin
-
Bolinder J, Ljunggren O, Johansson L, Wilding J, Langkilde AM, et al. (2014) Dapagliflozin maintains glycaemic control while reducing weight and body fat mass over 2 years in patients with type 2 diabetes mellitus inadequately controlled on metformin. Diabetes Obes Metab 16: 159-169.
-
(2014)
Diabetes Obes Metab
, vol.16
, pp. 159-169
-
-
Bolinder, J.1
Ljunggren, O.2
Johansson, L.3
Wilding, J.4
Langkilde, A.M.5
-
9
-
-
84864371186
-
Weight loss induced by chronic dapagliflozin treatment is attenuated by compensatory hyperphagia in diet-induced obese (DIO) rats
-
Devenny JJ, Godonis HE, Harvey SJ, Rooney S, Cullen MJ, et al. (2012) Weight loss induced by chronic dapagliflozin treatment is attenuated by compensatory hyperphagia in diet-induced obese (DIO) rats. Obesity (Silver Spring) 20: 1645-1652.
-
(2012)
Obesity (Silver Spring)
, vol.20
, pp. 1645-1652
-
-
Devenny, J.J.1
Godonis, H.E.2
Harvey, S.J.3
Rooney, S.4
Cullen, M.J.5
-
10
-
-
84884554260
-
Tofogliflozin, a novel sodium-glucose co-transporter 2 inhibitor, improves renal and pancreatic function in db/db mice
-
Nagata T, Fukuzawa T, Takeda M, Fukazawa M, Mori T, et al. (2013) Tofogliflozin, a novel sodium-glucose co-transporter 2 inhibitor, improves renal and pancreatic function in db/db mice. Br J Pharmacol 170: 519-531.
-
(2013)
Br J Pharmacol
, vol.170
, pp. 519-531
-
-
Nagata, T.1
Fukuzawa, T.2
Takeda, M.3
Fukazawa, M.4
Mori, T.5
-
11
-
-
84951906012
-
Energy Balance After Sodium-Glucose Cotransporter 2 Inhibition
-
Ferrannini G, Hach T, Crowe S, Sanghvi A, Hall KD, et al. (2015) Energy Balance After Sodium-Glucose Cotransporter 2 Inhibition. Diabetes Care 38: 1730-1735.
-
(2015)
Diabetes Care
, vol.38
, pp. 1730-1735
-
-
Ferrannini, G.1
Hach, T.2
Crowe, S.3
Sanghvi, A.4
Hall, K.D.5
-
12
-
-
74949093195
-
Evolution of sodium glucose cotransporter 2 inhibitors as anti-diabetic agents
-
Washburn WN (2009) Evolution of sodium glucose cotransporter 2 inhibitors as anti-diabetic agents. Expert Opin Ther Pat 19: 1485-1499.
-
(2009)
Expert Opin Ther Pat
, vol.19
, pp. 1485-1499
-
-
Washburn, W.N.1
-
13
-
-
77951240013
-
Community-based lifestyle modification of cardiovascular disease risks in middle-aged Japanese: A 27-month update
-
Fujii H, Muto T, Haruyama Y, Nakade M, Kobayashi E, et al. (2010) Community-based lifestyle modification of cardiovascular disease risks in middle-aged Japanese: a 27-month update. Tohoku J Exp Med 220: 307-318.
-
(2010)
Tohoku J Exp Med
, vol.220
, pp. 307-318
-
-
Fujii, H.1
Muto, T.2
Haruyama, Y.3
Nakade, M.4
Kobayashi, E.5
-
14
-
-
84859097891
-
Long-term efficacy of sitagliptin for the treatment of type 2 diabetic patients in Japan
-
Tajiri Y, Tsuruta M, Ohki T, Kato T, Sasaki Y, et al. (2012) Long-term efficacy of sitagliptin for the treatment of type 2 diabetic patients in Japan. Endocr J 59: 197-204.
-
(2012)
Endocr J
, vol.59
, pp. 197-204
-
-
Tajiri, Y.1
Tsuruta, M.2
Ohki, T.3
Kato, T.4
Sasaki, Y.5
-
15
-
-
0032522560
-
Epidemiology of sarcopenia among the elderly in New Mexico
-
Baumgartner RN, Koehler KM, Gallagher D, Romero L, Heymsfield SB, et al. (1998) Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol 147: 755-763.
-
(1998)
Am J Epidemiol
, vol.147
, pp. 755-763
-
-
Baumgartner, R.N.1
Koehler, K.M.2
Gallagher, D.3
Romero, L.4
Heymsfield, S.B.5
-
17
-
-
84908041063
-
Three percent weight reduction is the minimum requirement to improve health hazards in obese and overweight people in Japan
-
Muramoto A, Matsushita M, Kato A, Yamamoto N, Koike G, et al. (2014) Three percent weight reduction is the minimum requirement to improve health hazards in obese and overweight people in Japan. Obes Res Clin Pract 8: e466-475.
-
(2014)
Obes Res Clin Pract
, vol.8
, pp. e466-e475
-
-
Muramoto, A.1
Matsushita, M.2
Kato, A.3
Yamamoto, N.4
Koike, G.5
-
18
-
-
33846092266
-
A whole-body model to distinguish excess fluid from the hydration of major body tissues
-
Chamney PW, Wabel P, Moissl UM, Muller MJ, Bosy-Westphal A, et al. (2007) A whole-body model to distinguish excess fluid from the hydration of major body tissues. Am J Clin Nutr 85: 80-89.
-
(2007)
Am J Clin Nutr
, vol.85
, pp. 80-89
-
-
Chamney, P.W.1
Wabel, P.2
Moissl, U.M.3
Muller, M.J.4
Bosy-Westphal, A.5
-
19
-
-
0026638094
-
The five-level model: A new approach to organizing bodycomposition research
-
Wang ZM, Pierson RN Jr, Heymsfield SB (1992) The five-level model: a new approach to organizing bodycomposition research. Am J Clin Nutr 56: 19-28.
-
(1992)
Am J Clin Nutr
, vol.56
, pp. 19-28
-
-
Wang, Z.M.1
Pierson, R.N.2
Heymsfield, S.B.3
-
20
-
-
77953870112
-
Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People
-
Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, et al. (2010) Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing 39: 412-423.
-
(2010)
Age Ageing
, vol.39
, pp. 412-423
-
-
Cruz-Jentoft, A.J.1
Baeyens, J.P.2
Bauer, J.M.3
Boirie, Y.4
Cederholm, T.5
|